Mankind Pharma Acquires Majority Stake in Armed Cell Therapeutics
Mankind Pharma, through its Dutch subsidiary, signed a definitive agreement to invest EUR48 million for a 70% stake in Armed Cell Therapeutics. The newly formed Belgian company holds a preclinical portfolio of multi-targeting and…
